跳至主要内容
临床试验/CTRI/2017/09/009646
CTRI/2017/09/009646已完成4 期

Effect of infliximab therapy in functional improvement in patients with ankylosing spondylitis.

IPGMER SSKM Hospital0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. ASAS criteria fulfilled AS patients.
  • 2. Disease causing significant functional limitation.
  • 3. Active disease for >= 4weeks
  • 4. BASDAI >= 4
  • 5. Failed adequate NSAIDs trial.
  • 6. Patients giving consent for the study.
  • 7. Patient mentally sound enough to communicate and participate in the study and can understand the parameters well.

排除标准

  • 1. Active infection or septicaemia.
  • 2. Documented Hypersensitivity.
  • 3. Pregnancy.
  • 4. Recent history of malignancy.
  • 5. History of TB in recent past.
  • 6. Congestive cardiac failure (NYHA Class III-IV).
  • 7. Patients with Post myocardial infarction, Post stroke, Post mastectomy, prolonged immobilization.
  • 8. The presence of an unstable medical condition or a known uncontrolled systemic disease, including cancer, diabetes, endocrine disease, major depression, schizophrenia.

研究者

发起方
IPGMER SSKM Hospital

相似试验

Role of infliximab treatment in improvement of... | 临床试验